Takeda Pharmaceutical Co. Ltd., 10% Owner at Phathom Pharmaceuticals, Inc. (PHAT), sold 47,382 shares at $35.46 ($1.7M) on 2021-06-25, disclosed to the SEC on 2021-06-29.
Open-market sale of $1.7M PHAT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.46 | 22,881 | $811K | 48.3% |
| 2 | $35.46 | 22,881 | $811K | 48.3% |
| 3 | $36.07 | 1,250 | $45K | 2.7% |
| 4 | $35.08 | 370 | $13K | 0.8% |
| Total | $35.47 avg | 47,382 | $1.7M | 100% |
| Filing → |
| DAWN | SELL | 2021-12-09 | $9.9M | — | Filing → |
| PHAT | SELL | 2021-11-08 | $20.9M | — | Filing → |
| PHAT | SELL | 2021-07-09 | $183K | — | Filing → |